Advances in radioligand theranostics in oncology

Show simple item record

dc.contributor.author Lawal, Ismaheel Opeyemi
dc.contributor.author Abubakar, Sofiullah O.
dc.contributor.author Ndlovu, Honest
dc.contributor.author Mokoala, Kgomotso M.G.
dc.contributor.author More, Stuart
dc.contributor.author Sathekge, Mike Machaba
dc.date.accessioned 2024-06-19T09:33:03Z
dc.date.issued 2024-05
dc.description.abstract Please read abstract in the article. en_US
dc.description.department Nuclear Medicine en_US
dc.description.embargo 2025-03-31
dc.description.librarian hj2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.uri https://link.springer.com/journal/40291 en_US
dc.identifier.citation Lawal, I.O., Abubakar, S.O., Ndlovu, H. et al. Advances in Radioligand Theranostics in Oncology. Molecular Diagnosis & Therapy 28, 265–289 (2024). https://doi.org/10.1007/s40291-024-00702-4. en_US
dc.identifier.issn 1177-1062 (print)
dc.identifier.issn 1179-2000 (online)
dc.identifier.other 10.1007/s40291-024-00702-4
dc.identifier.uri http://hdl.handle.net/2263/96534
dc.language.iso en en_US
dc.publisher Springer en_US
dc.rights © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024. The original publication is available at : https://link.springer.com/journal/40291. en_US
dc.subject Lutetium-177 DOTATATE (177Lu-DOTATATE) en_US
dc.subject Lutetium-177 prostate-specific membrane antigen (177Lu-PSMA) en_US
dc.subject Fibroblast activation protein (FAP) en_US
dc.subject Chemokine receptor 4 (CXCR4) en_US
dc.subject Radioligand en_US
dc.subject Theranostics en_US
dc.subject Oncology en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Advances in radioligand theranostics in oncology en_US
dc.type Postprint Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record